Better Healthcare Sector ETF: Vanguard's Broad VHT vs. Invesco's Biotechnology-Focused IBBQ

Robert Izquierdo, The Motley Fool

Sun, July 26, 2026 astatine 1:04 PM CDT 4 min read

The Vanguard Health Care ETF (NYSEMKT:VHT) offers wide assemblage vulnerability and little costs, portion the Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) provides a concentrated, higher-volatility play connected biotech innovation and pharmaceutical research.

Selecting a healthcare ETF requires a prime betwixt wide assemblage sum and concentrated sub-industry focus. This examination examines however a diversified elephantine similar the Vanguard money measures up against a much specialized biotech fund. Investors often usage these vehicles to seizure aesculapian innovation, but the hazard profiles disagree based connected the premix of unchangeable pharmaceutical giants and volatile biotech firms.

Snapshot (cost & size)

Beta measures terms volatility comparative to the S&P 500; beta is calculated from monthly returns implicit the disposable money past (up to 5 years). The 1-yr instrumentality represents full instrumentality implicit the trailing 12 months. Dividend output is the trailing-12-month organisation yield.

Costs are a superior differentiator here, arsenic the Vanguard money operates with an ultra-low 0.09% disbursal ratio, making it much affordable than the 0.19% charged by the Invesco fund. Additionally, the wide healthcare vulnerability provides a higher yield; the Vanguard money offers a 1.6% trailing-12-month payout, doubling the 0.8% output provided by its biotech-focused peer.

Performance & hazard examination

What's wrong

The Vanguard Health Care ETF employs a passive absorption benignant to replicate a benchmark of healthcare equities, chiefly utilizing a afloat replication strategy. Its largest positions see Eli Lilly (NYSE:LLY) astatine 14.19%, Johnson & Johnson (NYSE:JNJ) astatine 8.89%, and AbbVie (NYSE:ABBV) astatine 6.56%. The portfolio includes 411 holdings, spanning aesculapian services, equipment, and wellness technology. It was launched successful 2004. The Vanguard Health Care ETF has paid $4.72 per stock implicit the trailing 12 months, which connected its caller ~$303.31 stock terms works retired to a 1.6% yield.

The Invesco Nasdaq Biotechnology ETF tracks the Nasdaq Biotechnology Index, allocating astatine slightest 90% of its superior to companies successful the benchmark. Its largest positions see Amgen (NASDAQ:AMGN) astatine 8.13%, Vertex Pharmaceuticals (NASDAQ:VRTX) astatine 7.90%, and Gilead Sciences (NASDAQ:GILD) astatine 7.26%. The money holds 251 securities and undergoes a yearly creation reappraisal each December. It was launched successful 2021. The Invesco Nasdaq Biotechnology ETF has paid $0.26 per stock implicit the trailing 12 months, which connected its caller ~$32.46 stock terms works retired to a 0.8% yield.